Navigation Links
Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
Date:1/7/2008

or the treatment of ocular diseases, with a special focus on retinal pathologies. Created in May 2005, Fovea has a highly experienced board and management team. Last December 2007, it raised EUR30M ($44M) in a Series B financing from a strong, international syndicate of new and existing investors led by Forbion Capital Partners (Naarden, The Netherlands). All existing institutional investors participated in the round including Sofinnova Partners, Abingworth, GIMV, The Wellcome Trust and Credit Agricole Private Equity (CAPE).

Fovea has built a project portfolio including internal research programs on dry AMD, glaucoma (neuroprotection) and retinal dystrophies as well as clinical programs underway for such indications as macular edema, allergic conjunctivitis, and retinitis pigmentosa.

To advance the development and commercialization of its programs, FOVEA is working both independently and through collaborators including industrial partners like Novartis, Genzyme, and CombinatoRx, as well as with academic teams, like the Inserm unit U592, the Rothschild Ophthalmological Foundation, or the Johns Hopkins University.

For additional information about FOVEA and its programs, please visit http://www.fovea-pharma.com

Fovea Pharmaceuticals

Bernard Davitian

Chief Financial Officer

+33144164261

info@fovea-pharma.com

Press Contacts:

France

Marie-Carole de Groc

EuroRSCG C&O

+33158479507

marie-carole.de-groc@eurorscg.fr

US

Wendy Lau

Russo Partners, LLC

+1-212-845-4272

wendy.lau@russopartnersllc.com


'/>"/>
SOURCE Fovea Pharmaceuticals SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
2. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
3. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
4. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
5. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
6. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
7. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
8. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
9. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
10. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
11. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- TWi Pharmaceuticals, Inc. (4180.TT) today announced that it ... Food and Drug Administration (FDA) on its Abbreviated ... oral suspension, the generic equivalent to Par Pharmaceutical,s ... Hatch Waxman rules, it will be entitled to ... the pre-launch preparation of the generic drug.  However, ...
(Date:8/27/2014)... About 8 million Americans have peripheral arterial ... fatty plaque in the arteries, according to recent statistics. ... in incidences of diabetes and obesity, the Society ... Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... residents and fellows will be able to gain state-of-the-art ...
(Date:8/27/2014)... --  Los Angeles orthodontics expert, Dr. Isaac ... want to make their treatment even faster. With this ... patients have a powerful tool to use as they ... by most patients with all types of braces, letting ... AcceleDent® Aura system for a few minutes each day. ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that Chengxuan, a ... Chairman and Chief Executive Officer of the Company, informed ... American Depositary Shares ("ADSs") in the open market on ...
... of Disabled Adults and Children (FODAC) has partnered with Invacare ... of equipment and supplies to Joplin, Missouri. A massive F5 ... 2011, leaving much of the city in ruins. FODAC, with ... supply shipment to Joplin within 24 hours of the disaster. ...
Cached Medicine Technology:China Medical Technologies Announces the Purchase of its ADSs by Chengxuan in the Open Market 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 3
(Date:8/27/2014)... 2014 DiaSorin has announced that their ... Dihydroxyvitamin D,” will feature guest speaker Dr. Gregory A. ... for Health and Healing Integrative Medicine. Dr. Plotnikoff serves ... Institute for Health and Healing and as Senior Consultant, ... Minnesota. He also serves as a co-editor of the ...
(Date:8/27/2014)... Recently, Skmen.com, a renowned garment manufacturer and ... bodycon dresses . The company has rich experience in ... items in stock and ready to ship: celebrity bodycon ... sweater dresses and so forth. All of them are ... “We are proud to announce the new collection of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Taking its popular ... Steele Creek YMCA will host its largest crowd ... on Saturday, September 13 at YMCA Camp Thunderbird . ... race divisions: adult, youth and teams. Within each division, ... to their physical limit - for a worthy cause. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Today, Zane ... webinar on compliance tips for administering a premium reimbursement ... reform in full effect, compliance is top of mind ... transition to individual health insurance and premium reimbursement, there ... , In the 35 minute webinar, Zane Benefits President, ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s ... pioneer runner, Kathrine Switzer, most noted for her brave running ... a line of women’s running clothes that unites the history ... 261 Fearless Movement. , “It is such an ... DeBoom. “Kathrine is the original Skirt – she stood ...
Breaking Medicine News(10 mins):Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3Health News:Skmen.com Unveils Its New Celebrity Bodycon Dresses for Its Loyal Customers 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2
... ... through its ActiveBase Security™ solution, today announced it has been included in the list of ... Joseph Feiman, Neil MacDonald, John Pescatore, Earl Perkins April 14, 2010, by Gartner Inc. ... Tel Aviv, Israel (PRWEB) April ...
... cases stem from established risk factors, study finds, , ... to increase the odds of breast cancer in white women ... , For instance, for postmenopausal women in the study, "recent ... to play as big a role in Hispanics," said Dr. ...
... ... Spearhead Company,s Quality, Regulatory and Compliance Matters , ... Panama City, Fla. (PRWEB) April 26, 2010 -- ... appointment of Samuel Patton as the company’s chief quality and regulatory officer. He will ...
... ... publishes new e-book that helps people choose the right dentist to perform dental implant surgery. ... (PRWEB) April 26, ... launched her newest e-book, Dental Implants: The Five Questions You Must Ask Your ...
... ... announced a small business Internet video advertising program that can deliver first ... required for traditional web page search engine optimization. The Site Steering small ... promotional video, and using a proprietary method to distribute the video to ...
... BMJ , Nigel Hawkes, freelance journalist and Director of Straight ... investigates how the way that patients are allocated diagnostic codes ... hospital,s performance. It follows two articles published by ... rates to judge hospital performance is a bad idea. ...
Cached Medicine News:Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 2Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 3Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 4Health News:Breast Cancer Risks Not Same for Hispanic Women 2Health News:Breast Cancer Risks Not Same for Hispanic Women 3Health News:iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives 2Health News:New E-Book Explains the Facts About Dental Implants 2Health News:Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days 2Health News:Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days 3Health News:Is patient coding making hospitals appear better than they are? 2
... Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme ... the qualitative presumptive (firststep) detection of total ... serum. This ELISA should only be used ... are consistent with Lyme disease. Equivocal or ...
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
Medicine Products: